Astrup A, Breum L, Toubro S, et al. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double-blind trial.
Int J Obes Relat Metab Disord.
1992;16:269 - 277.
Molnar D, Torok K, Erhardt E, et al. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Int J Obes Relat Metab Disord.
2000;24:1573 - 1578.
Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Int J Obes Relat Metab Disord.
1994;18:99 - 103.
Boozer CN, Nasser JA, Heymsfield SB, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
Int J Obes Relat Metab Disord.
2001;25:316 - 324.
Norregaard J, Jorgensen S, Mikkelsen KL, et al. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
Clin Pharmacol Ther.
1996;60:679-686.
Astrup A, Breum L, Toubro S, et al. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double-blind trial.
Int J Obes Relat Metab Disord.
1992;16:269 - 277.
Molnar D, Torok K, Erhardt E, et al. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Int J Obes Relat Metab Disord.
2000;24:1573 - 1578.
Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Int J Obes Relat Metab Disord.
1994;18:99 - 103.
Boozer CN, Nasser JA, Heymsfield SB, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
Int J Obes Relat Metab Disord.
2001;25:316 - 324.
Norregaard J, Jorgensen S, Mikkelsen KL, et al. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
Clin Pharmacol Ther.
1996;60:679 - 686.
Astrup A, Breum L, Toubro S. Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
Obes Res.
1995;3:537S - 540S.
MedscapeWire. No association between reported adverse events and ephedra when consumed as directed. Available at:
http://www.medscape.com/MedscapeWire/2000/08...medwire.0816.Nol. Accessed August 16, 2000.
Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements.
Am J Health Syst Pharm. 2000;57:963 - 969.
MedscapeWire. No association between reported adverse events and ephedra when consumed as directed. Available at:
http://www.medscape.com/MedscapeWire/2000/08...medwire.0816.Nol. Accessed August 16, 2000.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
N Engl J Med. 2000;343:1833 - 1838.
Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements.
Am J Health Syst Pharm. 2000;57:963 - 969.
Physicians' Desk Reference For Herbal Medicines. Montvale, NJ: Medical Economics Co; 1998:827.
Samenuk D, Link M, Homoud M K, et al. Adverse cardiovascular events temporally associated with Ma Huang, an herbal source of ephedrine.
Mayo Clin Proc. 2002;77:12-16.
Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
Int J Obes Relat Metab Disord. 2002;26:593-604.
Meston CM, Heiman JR. Ephedrine-activated physiological sexual arousal in women.
Arch Gen Psychiatry. 1998;55:652-656.
Nishiguchi M, Kinoshita H, Higasa K, et al. The false positive reaction of the Triage panel drug-of-abuse by herbal drugs ma-huang (Ephedra sinica Ephedraceae).
Nippon Hoigaku Zasshi. 2001;55:331-338.
Bruno A, Nolte KB, Chapin J. Stroke associated with ephedrine use.
Neurology. 1993;43:1313-1316.
Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink.
J Clin Psychopharmacol.
1997;17(5):437-439.
Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang.
Am J Gastroenterol. 2001;96:1654-1655.
Nadir A, Agrawal S, King PD, et a.. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang.
Am J Gastroenterol. 1996;91:1436-1438.
Zaacks SM, Klein L, Tan CD, et al. Hypersensitivity myocarditis associated with ephedra use
J Toxicol Clin Toxicol. 1999;37:485-489.
Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: ephedrine nephrolithiasis.
Am J Kidney Dis. 1998;32:153-159.
Lee MK, Cheng BW, Che CT, et al. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation.
Toxicol Sci. 2000;56:424-430.
Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
JAMA. 2003;289:1537 - 1545.
Bent S, Tiedt TN, Odden MC, et al. The relative safety of ephedra compared with other herbal products.
Ann Intern Med. 2003;138:468 - 471.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.